A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis

Condition:   Allergic Rhinitis Interventions:   Drug: azelastine/fluticasone 137/50 mcg nasal spray;   Drug: Dymista™ Sponsor:   Synmosa Biopharma Corp. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials